Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis
تاريخ النشر : 2020-12-10 20:05:07
عدد المشاهدات : 2
تاريخ النشر : 2020-12-10 20:05:07
عدد المشاهدات : 2
Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis | Research Topic |
هنادي محسن مهدي | Researcher Name |
Eastern Mediterranean Health Journal | Journal Name |
World Health Organization | Publisher |
1020-3397 | ISSN |
https://apps.who.int/iris/handle/10665/117823 | DOI |